• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1235300-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Death (1802); Myocardial Infarction (1969); Stenosis (2263); Respiratory Failure (2484)
Event Date 05/17/2017
Event Type  Death  
Manufacturer Narrative
The patient and device codes in f10 were coded by the manufacturer.(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the patient presented with coronary artery disease and an acute anterior wall myocardial infarction (awmi).The procedure on (b)(6) 2016 was to treat a lesion in the left anterior descending (lad) and left circumflex (cx) with moderate tortuosity, moderate calcification and 90% stenosis.Vessel sizing was done with intravascular ultrasound (ivus) with the vessel diameter determined to be greater than 2.5mm.A semi-compliant balloon was used for lesion preparation with residual stenosis reduced to less than 40%.A 3.0x28mm absorb gt1 scaffold was implanted and post-dilatation performed with a non-compliant balloon.The final angiographic residual stenosis was less than 10%.Ivus was performed to confirm that the scaffold was fully apposed to the vessel wall.The patient returned on (b)(6) 2017 with chest pain and awmi and subsequently restenosis was identified.The patient was intubated and a loading dose of ticagrelor was given.The restenosis was treated with the implantation of a non-abbott stent placed in the left main to lad; however, the patient condition was critical and the patient died on (b)(6)2017.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of angina, myocardial infarction, restenosis and death, as listed in the bioresorbable vascular scaffold (bvs) system, absorb gt1 instructions for use, are known adverse events associated with the use of a coronary scaffold in native coronary arteries.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
Subsequent to filing the initial mdr, the following information was received: the patient was confirmed to have been compliant with their dual anti-platelet therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6634963
MDR Text Key77379181
Report Number2024168-2017-04979
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/12/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/11/2018
Device Catalogue Number1235300-28
Device Lot Number6101461
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-